SCLN Financial Facts
Product sales: 39.46MTotal revenues: 40.54M
See Full Income Statement
Total liabilities and stockholders' equity: 233.36M
Accumulated other comprehensive income: 1.36M
See Full Balance Sheet
SciClone Pharmaceuticals, Inc. (SCLN) Earnings
|
Expand Research on SCLN
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +203.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/17  |
 |
Q416 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| 4/1/13 |
|
Q413 | $0.04 | $0.12 | -$0.08 | $33.1M | $35.3M |  |
 | | Details |
| 3/12/14 |
|
Q413 | $0.08 | $0.15 | -$0.07 | $32.7M | $38.3M | |
| | Details |
| 5/10/11 | Q111 | $0.08 | $0.10 | -$0.02 | $21.7M | $24.32M | = | | | Details | |
| 3/31/11 | Q111 | $0.08 | $0.11 | -$0.03 | $23.62M | $23.59M | = | | | Details | |
| 8/7/13 |
|
Q213 | $0.09 | $0.11 | -$0.02 | $29.81M | $33.3M | = | | | Details |
| 5/12/14 |
|
Q114 | $0.10 | $0.08 | +$0.02 | $26.6M | $32.2M | |
| | Details |
| 8/9/11 | Q211 | $0.13 | $0.10 | +$0.03 | $33.1M | $33.36M | = | | | Details |
